Skip to main content
Top
Published in: Health Economics Review 1/2023

Open Access 01-12-2023 | NSCLC | Correction

Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China

Authors: Huiqin Liu, Ying Wang, Qi He

Published in: Health Economics Review | Issue 1/2023

Login to get access

Excerpt

Correction: Health Econ Rev 12, 66 (2022)
Literature
Metadata
Title
Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China
Authors
Huiqin Liu
Ying Wang
Qi He
Publication date
01-12-2023
Publisher
Springer Berlin Heidelberg
Keywords
NSCLC
NSCLC
Published in
Health Economics Review / Issue 1/2023
Electronic ISSN: 2191-1991
DOI
https://doi.org/10.1186/s13561-023-00419-w

Other articles of this Issue 1/2023

Health Economics Review 1/2023 Go to the issue